• Home
  • Agric
  • Sci & Tech
  • Health
  • Environment
  • Hausa News
  • More
    • Business/Banking & Finance
    • POLITICS
    • Entertainments & Sports
    • International
    • Investigation
    • Law & Human Rights
    • Africa
    • ACCOUNTABILITY/CORRUPTION
    • Hassan Gimba
    • Column
    • Prof. Jibrin Ibrahim
    • Prof. M.K. Othman
    • Defense/Security
    • Education
    • Energy/Electricity
    • Entertainment/Arts & Sports
    • Society and Lifestyle
    • Food & Agriculture
    • Health & Healthy Living
    • International News
    • Interviews
    • Investigation/Fact-Check
    • LAW & HUMAN RIGHTS
    • Oil & Gas/Mineral Resources
    • PRESS FREEDOM/JOURNALISM/PR
    • General News
    • Presidency
  • About Us
    • Contact Us
    • Board Of Advisory
    • Privacy Policy
    • Ethics Policy
    • Teamwork And Collaboration Policy
    • Fact-Checking Policy
    • Advertising
  • Media OutReach Newswire
    • Wire News
  • The Stories
Facebook Twitter Instagram
Trending
  • Breast cancer: 58 Nigerian women die daily as treatment costs, late diagnosis worsen crisis
  • Ogun farmers call for better roads, security, inputs
  • PCN shuts illegal, non-compliant medicine outlets
  • Kaduna poultry farmers struggle with feed costs
  • AMR poses growing burden on families, expert warns
  • UCH wait times tied to staff shortage, weak primary care
  • UNICEF: 556,000 out-of-school children still await return to classrooms in Sokoto, Kebbi, Zamfara
  • Enugu residents call for steps to stabilise onion prices
Facebook Twitter Instagram YouTube
AsheNewsAsheNews
  • Home
  • Agric

    Ogun farmers call for better roads, security, inputs

    November 20, 2026

    Kaduna poultry farmers struggle with feed costs

    November 20, 2026

    Enugu residents call for steps to stabilise onion prices

    November 20, 2026

    IAR, NBMA train stakeholders on managing low-level presence of GM crops

    November 20, 2026

    PAN Kano plans accreditation for poultry input distributors

    November 20, 2026
  • Sci & Tech

    Expert calls for wider access to digital services in Nigeria

    November 20, 2026

    Rural connectivity key to inclusive digital growth, expert says

    November 20, 2026

    IAR, NBMA train stakeholders on managing low-level presence of GM crops

    November 20, 2026

    Sultan inaugurates 500-seat ICT centre at Saki nursing college, backs health technology expansion

    November 19, 2026

    Linking payment systems key to Africa’s trade integration, officials say

    November 19, 2026
  • Health

    Breast cancer: 58 Nigerian women die daily as treatment costs, late diagnosis worsen crisis

    November 20, 2026

    PCN shuts illegal, non-compliant medicine outlets

    November 20, 2026

    AMR poses growing burden on families, expert warns

    November 20, 2026

    UCH wait times tied to staff shortage, weak primary care

    November 20, 2026

    UNICEF support boosts safety, sanitation at Daudu camp

    November 20, 2026
  • Environment

    Ghana warns of El Niño-linked health risks as harmattan intensifies

    November 20, 2026

    Ghana’s UCC Vice-Chancellor meets 12-year-old student, urges focus on excellence

    November 20, 2026

    NEWSAN calls for urgent repairs to sewage systems

    November 19, 2026

    Nigeria targets open defecation free status by 2030

    November 19, 2026

    Erosion puts Cross River transmission line at risk

    November 19, 2026
  • Hausa News

    Foundation unveils public sector reform playbook

    November 12, 2026

    Tinubu asks Reps to approve N10.79tn external borrowing for 2026 budget

    November 11, 2026

    UNA signs MoU to launch air Bissau in Guinea-Bissau

    June 15, 2026

    Otti plans 250-room 5-star hotel in Umuahia

    April 11, 2026

    Anti-quackery task force seals 4 fake hospitals in Rivers

    August 29, 2025
  • More
    1. Business/Banking & Finance
    2. POLITICS
    3. Entertainments & Sports
    4. International
    5. Investigation
    6. Law & Human Rights
    7. Africa
    8. ACCOUNTABILITY/CORRUPTION
    9. Hassan Gimba
    10. Column
    11. Prof. Jibrin Ibrahim
    12. Prof. M.K. Othman
    13. Defense/Security
    14. Education
    15. Energy/Electricity
    16. Entertainment/Arts & Sports
    17. Society and Lifestyle
    18. Food & Agriculture
    19. Health & Healthy Living
    20. International News
    21. Interviews
    22. Investigation/Fact-Check
    23. LAW & HUMAN RIGHTS
    24. Oil & Gas/Mineral Resources
    25. PRESS FREEDOM/JOURNALISM/PR
    26. General News
    27. Presidency
    Featured
    Recent

    Breast cancer: 58 Nigerian women die daily as treatment costs, late diagnosis worsen crisis

    November 20, 2026

    Ogun farmers call for better roads, security, inputs

    November 20, 2026

    PCN shuts illegal, non-compliant medicine outlets

    November 20, 2026
  • About Us
    1. Contact Us
    2. Board Of Advisory
    3. Privacy Policy
    4. Ethics Policy
    5. Teamwork And Collaboration Policy
    6. Fact-Checking Policy
    7. Advertising
    Featured
    Recent

    Breast cancer: 58 Nigerian women die daily as treatment costs, late diagnosis worsen crisis

    November 20, 2026

    Ogun farmers call for better roads, security, inputs

    November 20, 2026

    PCN shuts illegal, non-compliant medicine outlets

    November 20, 2026
  • Media OutReach Newswire
    • Wire News
  • The Stories
AsheNewsAsheNews
Home»Health & Healthy Living»Study suggests effectiveness of malaria vaccine in young children
Health & Healthy Living

Study suggests effectiveness of malaria vaccine in young children

Study suggests effectiveness of malaria vaccine in young children
EditorBy EditorFebruary 2, 2024Updated:February 2, 2024No Comments3 Mins Read
Share
Facebook Twitter LinkedIn Pinterest Email

A malaria vaccine which has been developed with the help of Britain’s Oxford University scientists is up to 78 per cent effective in the youngest children, new data suggests.

In 2024, the R21/Matrix-M vaccine was recommended for use by the World Health Organisation (WHO).

While a new data from a phase 3 trial in African children confirms the jab is effective and safe.

Researchers immunized more than 4,800 young children in a trial in Burkina Faso, Kenya, Mali and Tanzania and found on average 78 Per cent efficacy in the five to 17-month age group over the first year.

The experts say that so far no other vaccine has reported more than 55 per cent effectiveness in the same age group.

According to the findings, published in The Lancet, a booster dose at a year maintained good efficacy over the following six to 12 months.

The overall efficacy was between 68 per cent and 75 per cent for children aged five to 36-months-old.

So far, 25 million doses have been manufactured and made ready for roll-out by the Serum Institute of India (SII) in the next three to four months.

Significantly increased immune responses to the vaccine, and slightly higher vaccine efficacy, were observed in five to 17-month-olds compared to 18 to 36-month-olds, supporting planned vaccine deployment initially from five months of age in African children.

Malaria is the largest cause of death in young African children, with 600,000 dying every year.

Two vaccines have recently achieved and completed WHO pre-qualification, and initial deployments are starting early this year.

Professor Adrian Hill, chief investigator of the R21/Matrix-M phase 3 trial, said: “The continued high efficacy of this new vaccine in field trials is very encouraging, and consistent with the high efficacy and excellent durability observed in a smaller four-year phase 2b trial.”

Audrey Duncanson, innovations transition manager at Welcome, said: “Malaria still remains a huge global health risk for nearly half of the world’s population.

However, with the burden of this disease predominantly in African countries causing approximately 600,000 deaths in children under the age of five years.

“The results from this recent phase 3 trial of the malaria vaccine, R21, hold huge potential for a transformative impact on malaria in children.

“This is an important step towards getting a highly effective, safe, readily accessible affordable vaccine to protect children from malaria in African countries.”

Adar Poonawalla, chief executive of SSI, said: “The Lancet study on R21/Matrix-M phase 3 trials marks a significant advancement in our battle against this global threat.

“We are dedicated to making this vaccine available, especially in Africa, where malaria poses a substantial threat to millions of lives, bringing us closer to a malaria-free world.”

The vaccine is cheap, costing between $2.00 (£1.65) and $4.00 (£3.30) per dose.

At least 28 countries in Africa plan to introduce WHO-recommended malaria jab as part of their national immunisation programmes.

Matrix-M adjuvant is manufactured by Novavax AB and provided to SII for formulation into the final vaccine drug product.

An adjuvant is an ingredient used in some vaccines to enhance the body’s immune response, which helps them to work better.

NAN

effectiveness Malaria vaccines Study
Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
Editor
  • Website

Related Posts

Breast cancer: 58 Nigerian women die daily as treatment costs, late diagnosis worsen crisis

November 20, 2026

PCN shuts illegal, non-compliant medicine outlets

November 20, 2026

AMR poses growing burden on families, expert warns

November 20, 2026

Leave A Reply Cancel Reply

Breast cancer: 58 Nigerian women die daily as treatment costs, late diagnosis worsen crisis

November 20, 2026

Ogun farmers call for better roads, security, inputs

November 20, 2026

PCN shuts illegal, non-compliant medicine outlets

November 20, 2026

Kaduna poultry farmers struggle with feed costs

November 20, 2026
About Us
About Us

ASHENEWS (AsheNewsDaily.com), published by PenPlus Online Media Publishers, is an independent online newspaper. We report development news, especially on Agriculture, Science, Health and Environment as they affect the under-reported rural and urban poor.

We also conduct investigations, especially in the areas of ASHE, as well as other general interests, including corruption, human rights, illicit financial flows, and politics.

Contact Info:
  • 1st floor, Dogon Daji House, No. 5, Maiduguri Road, Sokoto
  • +234(0)7031140009
  • ashenewsdaily@gmail.com
Facebook Twitter Instagram Pinterest
© 2026 All Rights Reserved. ASHENEWS Daily Designed & Managed By DeedsTech

Type above and press Enter to search. Press Esc to cancel.